165 related articles for article (PubMed ID: 7703491)
1. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma.
Yawetz S; Cumberland WG; van der Meyden M; Martínez-Maza O
Blood; 1995 Apr; 85(7):1843-9. PubMed ID: 7703491
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.
Schroeder JR; Saah AJ; Hoover DR; Margolick JB; Ambinder RF; Martinez-Maza O; Breen EC; Jacobson LP; Variakojis D; Rowe DT; Armenian HK
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):979-84. PubMed ID: 10566552
[TBL] [Abstract][Full Text] [Related]
3. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
4. Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue.
Schroeder JR; Saah AJ; Ambinder RF; Martinez-Maza O; Crabb Breen E; Variakojis D; Margolick JB; Jacobson LP; Rowe DT; Hoover DR
Clin Immunol; 1999 Dec; 93(3):239-44. PubMed ID: 10600334
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.
Bossolasco S; Nilsson A; de Milito A; Lazzarin A; Linde A; Cinque P; Chiodi F
AIDS; 2001 Jun; 15(9):1109-13. PubMed ID: 11416712
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected Rhesus monkeys.
Hannig H; Buske C; Mätz-Rensing K; Hunsmann G; Hiddemann W; Bodemer W
Int J Cancer; 1998 Aug; 77(5):734-40. PubMed ID: 9688307
[TBL] [Abstract][Full Text] [Related]
7. The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.
Breen EC; van der Meijden M; Cumberland W; Kishimoto T; Detels R; Martínez-Maza O
Clin Immunol; 1999 Sep; 92(3):293-9. PubMed ID: 10479534
[TBL] [Abstract][Full Text] [Related]
8. Serum measurements of soluble CD23 in HIV infection.
Bansal AS; Pumphrey RS; Mandal BK; Khoo SH; Wilson PB
Immunology; 1993 Dec; 80(4):652-3. PubMed ID: 7905861
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD23 controls IgE synthesis and homeostasis in human B cells.
Cooper AM; Hobson PS; Jutton MR; Kao MW; Drung B; Schmidt B; Fear DJ; Beavil AJ; McDonnell JM; Sutton BJ; Gould HJ
J Immunol; 2012 Apr; 188(7):3199-207. PubMed ID: 22393152
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
Breen EC; Fatahi S; Epeldegui M; Boscardin WJ; Detels R; Martínez-Maza O
Tumour Biol; 2006; 27(4):187-94. PubMed ID: 16651853
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
[TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
14. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE.
Saxon A; Ke Z; Bahati L; Stevens RH
J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844
[TBL] [Abstract][Full Text] [Related]
16. Aeroallergen-specific IgE changes in individuals with rapid human immunodeficiency virus disease progression.
Goetz DW; Webb EL; Whisman BA; Freeman TM
Ann Allergy Asthma Immunol; 1997 Mar; 78(3):301-6. PubMed ID: 9087157
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD23 (sCD23) serum levels and lymphocyte subpopulations in peripheral blood in rhinitis and extrinsic and intrinsic asthma.
Sánchez-Guerrero I; Albaladejo MD; García-Alonso AM; Muro M; Hernández J; Alvarez MR
Allergy; 1994 Sep; 49(8):587-92. PubMed ID: 7653734
[TBL] [Abstract][Full Text] [Related]
18. Elevated soluble CD23 level indicates increased risk of B cell non-Hodgkin's lymphomas: evidence from a meta-analysis.
Huang YS; Zhou X; Yang ZF; Lv ZT
Ann Hematol; 2018 Aug; 97(8):1317-1325. PubMed ID: 29750316
[TBL] [Abstract][Full Text] [Related]
19. Possible role of CD5+ B cells expressing CD23 in mediating the elevation of serum-soluble CD23 in patients with rheumatoid arthritis.
Ikizawa K; Yanagihara Y; Kajiwara K; Koshio T; Shida T; Yamada A
Int Arch Allergy Immunol; 1993; 101(4):416-24. PubMed ID: 7689005
[TBL] [Abstract][Full Text] [Related]
20. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
Chomarat P; Briolay J; Banchereau J; Miossec P
Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
